Rationally Engineered

Not all Cyclodextrins are created equally

Captisol® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly improving solubility, stability, bioavailability and dosing of active pharmaceutical ingredients (APIs).

Get Free SampleOrder Now

Social

June 11, 2018 FDA approves addition of positive overall survival data from Phase 3 ASPIRE trial to Kyprolis label https://t.co/us9tLCetBN
Your Partner in Solubility
The Clear Advantage

Partners

Merck
Baxter
Pfizer
Bristol-Myers Squibb
Amgen
Melinta
Lundbeck
Lilly
Celgene
Spectrum Pharmaceuticals